Clinical Trials Directory

Trials / Unknown

UnknownNCT02289391

Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia

Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia-single Center,Randomized,Double-blind,Controlled Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study try to illustrate the possible mechanisms of tending to induce airway spasms and the impact of dexmedetomidine on inflammatory reaction in general anesthesia patients with asthma,by detecting the differences of plasma inflammatory factor interleukin(IL)-4, IL-5, IL-13, IL-17, IL-33, MBP and immunoglobulin E(IgE) levels between asthma patients and non-asthma patients.

Conditions

Interventions

TypeNameDescription
DRUGAnesthesia induction-Intravenous injection midazolam 0.05 mg/Kg,fentanyl 4μg/Kg,etomidate 0.2 mg/Kg,cisatracurium 0.15 mg/Kg in proper order.
DRUGAnesthesia maintenance* Continuous intravenous remifentanil O.2μg/(kg•h) and propofol 3\~8mg/(kg•h). * Intermittent intravenous atracurium 0.05mg/kg. Maintain partial pressure of carbon dioxide(PETCO2) to 30\~40 mmHg and bispectral index (BIS) to 45\~60.
DRUGAssisted anesthesiaIntervention 'Assisted anesthesia' has been included in Arm Descriptions.

Timeline

Start date
2014-12-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-11-13
Last updated
2014-11-13

Source: ClinicalTrials.gov record NCT02289391. Inclusion in this directory is not an endorsement.